[Regulatory mechanisms of osteoclast development and bone disorders].
Inui
Masanori
M
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Seiryo 4-1, Aoba-ku, Sendai 980-8575, Japan.
Mori
Yu
Y
Takai
Toshiyuki
T
D048868:Adaptor Proteins, Signal Transducing; D001847:Bone Diseases / Q000188:drug therapy / Q000209:etiology*; D002352:Carrier Proteins / Q000502:physiology*; D002454:Cell Differentiation / Q000235:genetics*; D015195:Drug Design; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology*; D008565:Membrane Proteins; D010010:Osteoclasts / Q000166:cytology*; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; C512828:OSCAR protein, human; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; C110546:TYROBP protein, human; C505687:Tnfrsf11a protein, mouse; C505689:Tnfsf11 protein, mouse